Hänsel, Katrin
Dudgeon, Sarah N.
Cheung, Kei-Hoi
Durant, Thomas J. S.
Schulz, Wade L.
Funding for this research was provided by:
Immunohematology Transfusion Medicine Research Training Grant (2T32HL007974)
Article History
Received: 22 December 2022
Accepted: 15 April 2023
First Online: 17 May 2023
Declarations
:
: T.J.S.D. was a consultant for Roche, a diagnostics company (fees); was a consultant for Instrumentation Laboratories, a diagnostics company (fees). W.L.S. was a technical consultant to HugoHealth, a personal health information platform (equity, fees); is a cofounder of Refactor Health, an AI-augmented data management platform for healthcare (equity); was a consultant for Abbott, a diagnostics company (fees); received a speaker honorarium from Instrumentation Laboratories, a diagnostics company. K.H. reports no competing financial or non-financial interests. S.N.D. reports no competing financial or non-financial interests. K-H.C. reports no competing financial or non-financial interests. T.J.S.D. was a consultant for Roche, a diagnostics company (fees); was a consultant for Instrumentation Laboratories, a diagnostics company (fees). W.L.S. was a technical consultant to HugoHealth, a personal health information platform (equity, fees); is a cofounder of Refactor Health, an AI-augmented data management platform for healthcare (equity); was a consultant for Abbott, a diagnostics company (fees); received a speaker honorarium from Instrumentation Laboratories, a diagnostics company.